• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.15% Nasdaq Up1.37%

    OncoGenex Pharmaceuticals, Inc. (OGXI)

    -NasdaqCM
    3.13 Up 0.21(7.19%) 2:41PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Company EventsGet Company Events for:
    Upcoming Events 
    DateEvent
    Oct 28 - Nov 2, 2015 (Est.)Earnings announcement
    Recent Events 
    DateEvent
    13-Aug-15OncoGenex Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
    13-Aug-15ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen
    13-Jul-15ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
    10-Jun-15KB Home Earnings Call scheduled for 12:00 pm ET today
    22-May-15ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,
    14-May-15OncoGenex Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
    14-May-15ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen
    30-Apr-15ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Mate
    27-Apr-15ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclos
    26-Mar-15ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen
    12-Feb-15ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Mate
    30-Dec-14ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclos
    19-Dec-14ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
    30-Oct-14ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen
    7-Aug-14ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Director